查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
真皮填充劑市場 - 預測 2023-2028
市場調查報告書
商品編碼
1279586

真皮填充劑市場 - 預測 2023-2028

Dermal Fillers Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 165 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

真皮填充劑市場預計將以 8.57% 的複合年增長率增長，從 2021 年的 31.48 億美元增至 2028 年的 55.97 億美元。 真皮填充劑是為尋求增強和改變當前面部外觀的顧客提供的美容注射。 想要改善面部下垂皮膚（例如臉頰、嘴唇和下巴輪廓）、想要提升面部外觀、想要增加質量以及想要塑造對稱性的消費者選擇真皮填充劑。面部特徵。這是一個標準程序 皮膚科醫生、醫院、醫療水療中心等出售不同類型的皮膚填充劑。 客戶可以立即看到結果，並且可以持續數月至數年，具體取決於所選的真皮填充劑類型。

真皮填充劑因其能夠有效逆轉患者皮膚衰老跡象並增加目標面部區域的額外體積而廣受歡迎。 例如，印度 Ka□□ya Clinic 的 Juvederm 真皮填充劑保證顧客在註射到皮膚後一周內立即看到效果。 曬傷、細紋、眼睛凹陷、皮膚變色和許多其他皮膚瑕疵都是由面部組織體積減少引起的。 通過注射真皮填充劑，使用者可以受益於減少所有此類皮膚缺陷的出現。 除此之外，真皮填充劑有助於增加註射區域的膠原蛋白和彈性蛋白含量，這有利於恢復皮膚健康。 儘管消費者可以選擇多種護膚產品和方案，但真皮填充劑提供的效果質量優異，因此，國際真皮填充劑市場的市場規模正在不斷擴大。

低風險、非手術、微創手術的增加預計將推動市場增長。

注射到患者皮膚中的真皮填充劑是一種非手術程序。 因此，這是一種微創手術，不需要客戶進行整容手術或麻醉即可達到預期效果。 美容協會發布的年度報告強調，到 2021 年，真皮填充手術的數量將達到約 180 萬例，而其他皮膚緊緻治療的數量為 39 萬例。 這顯示了人們對真皮填充劑的興趣，因為它們具有多種面部效果和低風險。 因此，考慮到這些推動真皮填充劑市場需求的關鍵因素，預計在預測期內市場規模將繼續增加。

類似美容療法之間的激烈競爭可能會限制真皮填充劑市場的增長。

除了真皮填充劑之外，還有一些美容手術和皮膚護理服務可以提供與真皮填充劑類似的效果。 肉毒桿菌、射頻面部治療、激光換膚、微針和其他面部復興治療。 除了這些現有的方法之外，製藥公司和護膚品牌還定期採用新技術和治療方法進行創新。 例如，美國皮膚科診所 ForeverSlender Medspa 創新了一種名為 Ultralift 的真皮填充劑的新型非手術替代品。 因此，真皮填充劑其他替代品的存在可能會減緩真皮填充劑市場的擴張。

北美預計將在通用真皮填充劑市場中佔據很大份額。

北美國家越來越多的微創美容手術以及皮膚診所服務和美容導致對真皮填充劑的高需求和消費。 此外，對真皮填充劑和其他美容治療的需求不斷增長，吸引了外國公司進軍北美市場。 例如，專注於高端醫療保健和護膚產品的德國公司Amalia宣佈在加拿大開設診所並提供優質真皮填充劑。 此外，北美醫療保健和美容公司正在積極投資新產品的推出，包括真皮填充劑。 例如，美國製藥公司艾伯維（AbbVie）正在通過其子公司品牌艾爾建美學（Allergan Aesthetics）開發並推出一系列新的真皮填充劑產品。 因此，考慮到北美真皮填充劑市場快速擴張背後的因素，北美真皮填充劑市場的擴張是可期的。

內容

第 1 章簡介

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場細分
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表

第 2 章研究方法

  • 調查數據
  • 調查設計
  • 驗證

第 3 章執行摘要

  • 調查要點

第 4 章市場動態

  • 市場促進因素
  • 市場抑制因素
  • 波特五力分析
  • 行業價值鏈分析

第 5 章真皮填充劑市場：按產品類型

  • 簡介
  • 可生物降解
  • 不可生物降解

第 6 章真皮填充劑市場：按應用分類

  • 簡介
  • 臉部線條修正
  • 整容
  • 強化嘴唇
  • 其他

第 7 章真皮填充劑市場：按材料

  • 簡介
  • 透明質酸
  • 羥基磷灰石鈣
  • 聚-L-乳酸
  • 聚甲基丙烯酸甲酯微球
  • 其他

第 8 章真皮填充劑市場：按最終用戶劃分

  • 簡介
  • 皮膚科診所
  • 醫院
  • 其他

第 9 章真皮填充劑市場：按應用分類

  • 簡介
  • 臉
  • 全身

第 10 章真皮填充劑市場：按地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 印度尼西亞
    • 泰國
    • 越南
    • 其他

第 11 章競爭格局與分析

  • 主要公司及戰略分析
  • 新興公司和市場盈利能力
  • 合併、收購、協議與合作
  • 供應商競爭力矩陣

第 12 章公司簡介

  • Sinclair
  • Suneva Medical
  • Merz Pharma
  • Abbvie Inc.（ALLEGRAN）
  • Galderma Laboratories, L.P.
  • Croma Pharma
  • Cytophil, Inc.
  • Humedix
  • Prollenium Medical Technologies
簡介目錄
Product Code: KSI061614648

The dermal fillers market is projected to grow at a CAGR of 8.57%, reaching US$5.597 billion in 2028 from US$3.148 billion in 2021. Dermal fillers are cosmetic injections given to customers seeking to enhance and alter the current appearance of their faces. Dermal fillers are a standard procedure opted for by consumers who wish to reduce the sagging appearance of their facial skin, uplift the facial appearance, increase the mass, or enhance the symmetry of their facial features such as cheeks, lips, and jawlines. An extensive range of different types of dermal fillers is available for consumers through dermatology clinics, hospitals, and medical spas. The customers can notice immediate results and based on the type of dermal filler opted for, the results might be effective for a few months or years.

Dermal fillers are gaining popularity due to their efficiency in restoring the aging signs of the patient's skin and adding extra volume to the targeted facial part. For instance, the Juvederm dermal filler by Kaya Clinic in India guarantees immediate results to its customer within one week of injecting it into the skin. Various skin concern factors such as sun damage, fine lines, wrinkles, sunken eyes, and skin discoloration result from the loss of volume in the face tissues. By injecting dermal fillers, the user can benefit from reducing the appearance of all such skin concerns. Apart from this, the dermal fillers help construct collagen and elastin content in the injected area, which are beneficial to restore the skin's health. Even though there are several skincare products and regimens which can opt for by consumers, the result offered by dermal fillers is of superior quality, due to which the international dermal fillers market is witnessing an increased market size.

An increasing number of low-risk non-surgical, and minimally invasive procedures are expected to boost the market growth.

The dermal fillers injected into the patient's skin are non-surgical procedures. Therefore, it is a minimally invasive procedure that does not require its customer to undergo a cosmetic operation or receive anesthesia to achieve the desired outcome. The annual report released by The Aesthetic Society highlighted that the number of dermal filler procedures in 2021 amounted to approximately 1.8 million, whereas other skin tightening treatment procedures amounted to 0.39 million. This demonstrates interest in dermal fillers owing to their various face enhancement benefits and low-risk features. Therefore, considering these key factors driving demand for the dermal filler market, it can be anticipated that it will continue to expand its market size over the forecast period.

The intense competition offered by similar cosmetic procedures will likely restrain the growth of the dermal fillers market.

Apart from dermal fillers, there are several cosmetic procedures and skin care services that provide similar results as dermal fillers. Botox, radio frequency-based face treatments, laser skin resurfacing method, micro-needling, and other facial revitalization treatments. Apart from these existing methods, pharmaceutical and skincare brands regularly innovate new techniques and treatments. For instance, ForeverSlender Medspa, a skin clinic based in the USA, has innovated a new non-surgical alternative for dermal fillers named Ultralift. Therefore, the existence of other options for derma fillers has the potential to slow down the expansion of the dermal fillers market.

Market Developments

  • In June 2022, Croma Aesthetics Canada Ltd. introduced a new derma filler product, Saypha Volume Plus, with hyaluronic acid as its vital ingredient under its subsidiary brand Hugel Aesthetics. This derma filler targets restoring the original volume of the face.
  • In June 2021, Medytox Inc. expanded its operations to Taiwan and announced a collaboration with Dynamic Medical Technologies Company to manufacture hyaluronic-acid-based dermal fillers.
  • In February 2020, BioScience GmbH, specializing in the manufacture of aesthetic cosmetology products, introduced a new product line consisting of two new derma fillers of varying density levels.

North America is expected to hold a significant share of the universal dermal fillers market.

The increase in minimally-invasive cosmetic procedures across North American countries and the rise in skin clinic services and aesthetics are resulting in high demand and consumption of dermal fillers. Furthermore, the rising need for derma fillers and other cosmetic treatments is attracting branches of foreign companies into the North American market. For instance, Amalian, a German company specializing in high-end healthcare and skincare products, has announced its clinic's launch and superior-quality dermal fillers in Canada. In addition, healthcare and beauty companies in North America are actively investing in launching new products, including dermal fillers. For instance, AbbVie Company, a US-based pharmaceutical company, has been developing and launching new dermal filler product lines through its subsidiary brand, Allergan Aesthetics. Therefore, considering the factors influencing the rapid market growth of dermal fillers in North America, it can be anticipated that North America shall experience expansion in the dermal fillers market.

Market Segmentation

By Product Type

  • Biodegradable
  • Non-biodegradable

By Application

  • Facial Line Correction
  • Face Lift
  • Lip Enhancement
  • Others

By Material

  • Hyaluronic Acid
  • Calcium Hydroxylapatite
  • Poly-L-Lactic Acid
  • Polymethyl-Methacrylate Microspheres
  • Others

By End-User

  • Dermatology Clinics
  • Hospitals
  • Others

By Geography

  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Vietnam
    • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Research Design
  • 2.3. Validation

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. DERMAL FILLERS MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Biodegradable
  • 5.3. Non- Biodegradable

6. DERMAL FILLERS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Facial Line Correction
  • 6.3. Face Lift
  • 6.4. Lip Enhancement
  • 6.5. Others

7. DERMAL FILLERS MARKET BY MATERIAL

  • 7.1. Introduction
  • 7.2. Hyaluronic Acid
  • 7.3. Calcium Hydroxylapatite
  • 7.4. Poly-L-Lactic Acid
  • 7.5. Polymethyl-Methacrylate Microspheres
  • 7.6. Others

8. DERMAL FILLERS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Dermatology Clinics
  • 8.3. Hospitals
  • 8.4. Others

9. DERMAL FILLERS MARKET BY APPLICATION

  • 9.1. Introduction
  • 9.2. Face
  • 9.3. Full body

10. DERMAL FILLERS MARKET BY GEOGRAPHY

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. USA
    • 10.2.2. Canada
    • 10.2.3. Mexico
  • 10.3. South America
    • 10.3.1. Brazil
    • 10.3.2. Argentina
    • 10.3.3. Others
  • 10.4. Europe
    • 10.4.1. Germany
    • 10.4.2. France
    • 10.4.3. United Kingdom
    • 10.4.4. Spain
    • 10.4.5. Others
  • 10.5. Middle East And Africa
    • 10.5.1. Saudi Arabia
    • 10.5.2. UAE
    • 10.5.3. Israel
    • 10.5.4. Others
  • 10.6. Asia Pacific
    • 10.6.1. China
    • 10.6.2. Japan
    • 10.6.3. India
    • 10.6.4. South Korea
    • 10.6.5. Indonesia
    • 10.6.6. Thailand
    • 10.6.7. Vietnam
    • 10.6.8. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Emerging Players and Market Lucrativeness
  • 11.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 11.4. Vendor Competitiveness Matrix

12. COMPANY PROFILES

  • 12.1. Sinclair
  • 12.2. Suneva Medical
  • 12.3. Merz Pharma
  • 12.4. Abbvie Inc. (ALLEGRAN)
  • 12.5. Galderma Laboratories, L.P.
  • 12.6. Croma Pharma
  • 12.7. Cytophil, Inc.
  • 12.8. Humedix
  • 12.9. Prollenium Medical Technologies